Sort   by:  
 Page size 
UnknownProlonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905.
Not available
S-EPMC3986386 | biostudies-literature
Unknown<i>G</i>lioma <i>r</i>esource <i>o</i>utreach <i>w</i>ith <i>s</i>upport: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.
Not available
S-EPMC11798613 | biostudies-literature
UnknownEvaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Not available
S-EPMC10406420 | biostudies-literature
UnknownRe-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.
Not available
S-EPMC10689476 | biostudies-literature
UnknownA low percentage of metastases in deep brain and temporal lobe structures.
Not available
S-EPMC6502494 | biostudies-literature
UnknownAzacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study.
Not available
S-EPMC4794257 | biostudies-literature
UnknownActivity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
Not available
S-EPMC8730772 | biostudies-literature
UnknownClinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.
Not available
S-EPMC9248387 | biostudies-literature
UnknownSequence analysis of mutations and translocations across breast cancer subtypes.
Not available
S-EPMC4148686 | biostudies-literature
UnknownMechanisms and therapeutic implications of hypermutation in gliomas.
Not available
S-EPMC8235024 | biostudies-literature
Sort   by:  
 Page size